The TNM staging system is the international gold standard for staging cancers and is revised regularly in the light of current evidence. There are two versions of this system published in parallel by the Union for International Cancer Control (UICC) and American Joint Committee on Cancer (AJCC). The 8th edition (TNM8), the latest revision of both classifications published in 2016 includes major changes to the clinical staging of prostate cancer. Clinical staging is particularly important in assessing the spread of prostate cancer as a final pathological stage would be available only in those patients who undergo radical prostatectomy. This article is protected by copyright. All rights reserved.
BJU international. 2018 Oct 13 [Epub ahead of print]
Murali Varma, Dennis Cochlin, Brett Delahunt, Howard Kynaston, John Rees, Brian Rous, Krishna Narahari
Departments of Pathology, Cardiff and Vale University Heath Board, Cardiff, UK., Departments of Radiology, Cardiff and Vale University Heath Board, Cardiff, UK., Departments of Pathology, Wellington School of Medicine and Health Sciences, Wellington, New Zealand., Departments of Urology, Cardiff and Vale University Heath Board, Cardiff, UK., Departments of Pathology, National Cancer Registration and Analysis Service, Cambridge, UK.